Positioning of Esketamine Treatment in the Real-world Management of Depression
Status:
Recruiting
Trial end date:
2026-01-15
Target enrollment:
Participant gender:
Summary
The goal of this naturalistic, open label, single arm intervention study is to investigate
the effects of Esketamine in treating depression.The main aims to answer are:
- to investigate whether Esketamine is effective when added to ongoing antidepressant
treatment
- to identify patient characteristics that will determine a therapeutic response to
Esketamine in real-world practice
Participants will:
- attend the clinic for supervised self-administration of intranasal Esketamine treatment
- be observed for 2 hours following Esketamine administration including blood pressure
monitoring
- be asked to complete a battery of questionnaires
- be reimbursed for travel expenses